EN
HI
Sun Pharma Advanced Research Company Chart
Sun Pharma Advanced Research Company Share Key Metrics
Volume
30.24 L
Market Cap
5473.66 CR
LTQ@LTP
50@168.68
ATP
171.81
Var Margin
25.36 %
Circuit Range
133.15-199.71
Delivery %
32.21 %
Value
51.96 CR
ASM/GSM
No
Market Lot
1
Summary
Sun Pharma Advanced Research Company share price stands at ₹168.68 at 13 May, 2026 | 15:58. The stock Sun Pharma Advanced Research Company intraday movement has stayed between ₹165.00 and ₹175.60, while on a 52-week basis it has fluctuated from ₹108.00 to ₹204.40.
In terms of trading activity, Sun Pharma Advanced Research Company has recorded a volume of 3024126 shares. The Sun Pharma Advanced Research Company has a market cap of ₹324499558. The stock’s Average Traded Price (ATP) stands at ₹17181, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50, 16868.
The Sun Pharma Advanced Research Company operates within a circuit range of ₹133.15-199.71 – ₹133.15-199.71, with a Value of ₹51.96 CR. The Delivery Percentage for the day is 32.21%. Additionally, Sun Pharma Advanced Research Company currently falls under the No framework, and trades with a market lot size of 1.
Sun Pharma Advanced Research Company Fundamentals
View MoreP/E Ratio
0
P/B Ratio
-12.73
Div. Yield
0
Sector P/E
24.93
Sector P/B
2.65
Sec. Div. Yield
1.06
Sun Pharma Advanced Research Company Resistance and Support
Pivot 167.08
Resistance
First Resistance
172.15
Second Resistance
177.86
Third Resistance
182.93
Support
First Support
161.37
Second Support
156.3
Third Support
150.59
Sun Pharma Advanced Research Company Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-18 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2026-01-14 | To consider issue of Warrants & ESOP |
| 2025-11-10 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results |
Sun Pharma Advanced Research Company News
Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026
Sun Pharma Advanced Research Co board will convene on May 18, 2026, to consider and approve its Q4 FY26 and full-year FY26 financial results. This meeting will finalize the company's financial performance for the period ending March 31, 2026.
May 11 2026 19:05:00
Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma Advanced Research Co (SPARC) announced the sale of its Rare Paediatric Disease Priority Review Voucher for US $195 million. This strategic divestment aims to accelerate the development of pipeline assets and strengthen its external innovation strategy.
Apr 30 2026 09:04:00
Read More
About Sun Pharma Advanced Research Company
NSE : 14788
BSE : 532872
ISIN : INE232I01014
Sun Pharma Advanced Research Company Management
| Name | Position |
|---|---|
| Kajal Damania | Company Secretary & Compliance Officer |
| Dilip S Shanghvi | Chairman |
Sun Pharma Advanced Research Company Similar Stocks
Wework India Management Ltd.
494.40
-2.30 (0.46%)
JK Paper Ltd.
384.95
-6.15 (1.57%)
Latent View Analytics Ltd.
296.65
2.30 (0.78%)
Ion Exchange (India) Ltd.
395.20
2.10 (0.53%)
Elitecon International Ltd.
32.34
-1.21 (3.61%)
SIS Ltd.
373.95
0.50 (0.13%)
Symphony Ltd.
777.20
12.35 (1.61%)
Entero Healthcare Solutions Ltd.
1178.90
-31.40 (2.59%)
Smartworks Coworking Spaces Ltd.
444.75
16.35 (3.82%)
GNG Electronics Ltd.
420.60
-10.70 (2.48%)
Sun Pharma Advanced Research Company FAQs
The Buying Price of Sun Pharma Advanced Research Company share is 168.68 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sun Pharma Advanced Research Company stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sun Pharma Advanced Research Company, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sun Pharma Advanced Research Company shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sun Pharma Advanced Research Company shares is -12.73. Useful to assess the stock's value relative to its book value.
To assess Sun Pharma Advanced Research Company’s valuation compare Sector P/E, P/B which are 24.93 & 2.65 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sun Pharma Advanced Research Company is 5473.66 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sun Pharma Advanced Research Company share price is 204.40 & 108.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sun Pharma Advanced Research Company belongs to the Miscellaneous sector.
